Inside the Briefcase

FICO Scales with Oracle Cloud

FICO Scales with Oracle Cloud

Doug Clare, Vice President at FICO, describes how Oracle...

Is Your Enterprise IT the Best It Can Be?

Is Your Enterprise IT the Best It Can Be?

Enterprise IT is a driver of the global economy....

The IoT Imperative for Consumer Industries

The IoT Imperative for Consumer Industries

This IDC white paper examines current and future...

How to align your visual brand guidelines and create consistently on-brand content

How to align your visual brand guidelines and create consistently on-brand content

In this ebook, we’ll explore the various themes leading...

Your B2B Content Strategy in 2017: How To Think Like A Movie Studio + 6 Other Tactics

Your B2B Content Strategy in 2017: How To Think Like A Movie Studio + 6 Other Tactics

Jon Lombardo, Creative Lead, LinkedIn, reveals in this presentation...

Biopharma Leaders Discuss Pharma’s Future at Pharmaceutical Strategic Alliances in New York

August 8, 2011 No Comments

SOURCE:  PR Newswire

Elsevier Business Intelligence, the biopharma industry’s leading provider of strategic business intelligence and conferences, is hosting Windhover’s 21st Pharmaceutical Strategic Alliances (PSA) September 21-23, 2011 at the Millennium Broadway in New York, NY.

PSA is the only conference of its kind to provide direct access to such a diverse mix of pharma’s top talent. It’s an opportunity to hear first-hand from some of the industry’s most influential minds and leading experts. Chief Executive Officers Lamberto Andreotti of Bristol-Myers Squibb and George Scangos of Biogen Idec are just two of the speakers providing perspectives – and solutions – to the top challenges facing biopharma companies big and small.

Read More

DATA and ANALYTICS , HEALTH IT, News

Leave a Reply

(required)

(required)


ADVERTISEMENT

IBC 2017

ITBriefcase Comparison Report